DYOR. Analysis is speculative to understand potential value of the indication to Big Pharma and implied value to shareholders.I've tacked a revenue model for Pancreatic Cancer onto the right-hand end of the figures below. I have kept it separate from the total for the 3-pillar strategy.
Assumptions:
Results - risked value per share for Pancreatic cancer at $1.17 per share, risked post-tax NPV for Pancreatic Cancer at AUD $228M ( 50% clinical probability and 20% discount rate applied ).
- 50% probability of success as per FTO and discount rate 25% given the lower clinical probability.
- Incidence for Pancreatic Cancer from sources below.
- 5% share of treatment
- Pricing Based on average USD $333k for midpoint 900 patients against revenue USD $300M, https://www.fiercebiotech.com/special-report/20-tibsovo
- Ledley FD, McCoy SS, Vaughan G, Cleary EG. Profitability of Large Pharmaceutical Companies Compared With Other Large Public Companies.
- http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/pedata.html
- Fully-diluted share issue assumed at 200M shares ( current is 162M shares ).
Note - Keytruda, which I have used as the basis of Revenue Potential for FTO at USD $24.91B is currently approved for 30 indications (first approval in 2014). So each indication averages at USD $0.83 revenue.
https://www.drugs.com/history/keytruda.html
My chart of the growth in approvals for Keytruda.
- Forums
- ASX - By Stock
- RAC
- The RAC 3-Pillar Trifecta
The RAC 3-Pillar Trifecta, page-187
-
- There are more pages in this discussion • 238 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
-0.060(3.79%) |
Mkt cap ! $259.9M |
Open | High | Low | Value | Volume |
$1.54 | $1.56 | $1.53 | $130.2K | 84.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4993 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 10451 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4993 | 1.525 |
1 | 12381 | 1.520 |
3 | 9872 | 1.510 |
3 | 11327 | 1.505 |
9 | 14363 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.580 | 10451 | 1 |
1.595 | 6000 | 1 |
1.600 | 23239 | 1 |
1.630 | 6183 | 1 |
1.650 | 17029 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |